跳至主要内容
临床试验/CTRI/2022/03/041489
CTRI/2022/03/041489已完成2 期

A pilot study to evaluate the safety and efficacy of Gunmakudori Mezhugu (GKM) in the management of Garpa vayu (PCOS) in the women of reproductive age.

Central Council for Research in Siddha0 个研究点目标入组 34 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age limit 18 years to 45 years.
  • 2.PCOS women diagnosed by Rotterdam criteria.
  • 3.Presence with Oligomenorrhea or Amenorrhea after negative screening pregnancy test.
  • 4.Hyperandrogenism clinically Hirsutism, Biochemically elevated serum testosterone concentrations.
  • 5.Polycystic ovaries.

排除标准

  • 1.Age younger than 18 or older than 45
  • 2.Hyperandrogenism due to other reasons including hyperprolactinemia, thyroid diseases, congenital adrenal hyperplasia, Cushing syndrome etc.
  • 3.Subjects with metabolic, endocrinal disorders and psychiatric illnesses.
  • 4.Not associated with any organic reproductive system abnormalities.
  • 5.Current or previous (within the last 3 months) use of oral contraceptives.
  • 6.Pregnant or suspected to be pregnant.

研究者

发起方
Central Council for Research in Siddha

相似试验

A Pilot study to evaluate the safety and efficacy of... | 临床试验